Center for Neuroscience of Psychedelics, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
5Articles
13.3KReads1
2024–2026Active
20Collaborators
2Citations2
About
Franklin King IV, MD, is affiliated with the Center for Neuroscience of Psychedelics at Massachusetts General Hospital and the Department of Psychiatry at Harvard Medical School. His publications from 2024 to 2026 focus on the psychiatric and medical aspects of psychedelics, including their psychological adverse effects and medical complications. He has also contributed to literature on depression, moral injury, and patient communication in gastroenterology and primary care settings. His work frequently addresses clinical guidance for discussing inflammatory bowel diseases and psychedelics with patients.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
